Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia

Edward J Golob1, Rie Irimajiri, Arnold Starr

  • 1Department of Neurology, University of California, Irvine, CA, USA. egolob@tulane.edu

Insights

Auditory sensory potentials, specifically P50 amplitude, show distinct patterns in mild cognitive impairment (MCI) patients. These changes can differentiate subtypes and predict conversion to Alzheimer's disease, offering a potential diagnostic biomarker.

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Biomarkers

Background:

  • Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD).
  • Amnestic MCI, characterized by episodic memory deficits, has subtypes: single domain (SD) and multiple domain (MD).
  • Previous research noted altered auditory cortical potentials in MCI, but subtype and outcome associations were unclear.

Purpose of the Study:

  • To investigate auditory sensory and cognitive potentials (P50, N100, P300) in amnestic MCI subtypes.
  • To determine the relationship between these potentials and clinical outcomes (MCI-stable vs. MCI-convert to AD) over 5 years.
  • To compare findings in MCI with young controls, older controls, and mild AD patients.

Main Methods:

  • Auditory evoked potentials (P50, N100, P300) were recorded during an auditory discrimination task.
  • Participants included amnestic MCI (SD and MD subtypes), probable AD, young controls, and age-matched older controls.
  • MCI patients were followed for up to 5 years to classify outcomes: MCI-stable or MCI-convert to probable AD.

Main Results:

  • P50 amplitude increased with normal aging and was further elevated in MCI.
  • Elevated P50 amplitude was significantly higher in multiple domain (MD) MCI than single domain (SD) MCI.
  • Higher P50 amplitude in MCI predicted conversion to probable AD (MCI-convert > MCI-stable).
  • P300 latency increased with aging and MCI, but did not differentiate outcomes.

Conclusions:

  • Auditory sensory potentials, particularly P50 amplitude, differ between amnestic MCI subtypes.
  • P50 amplitude serves as a potential biomarker for predicting progression from MCI to Alzheimer's disease.
  • These findings highlight the utility of auditory evoked potentials in understanding MCI heterogeneity and prognosis.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...